| 标题 |
 Low dose interferon-α2b (IFN) + thalidomide (T) in patients (pts) with previously untreated renal cell cancer (RCC). Improvement in progression-free survival (PFS) but not quality of life (QoL) or overall survival (OS). A phase III study of the Eastern Cooperative Oncology Group (E2898) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：M. S. Gordon; J. Manola; D. Fairclough; D. Cella; R. Richardson; et al 出版日期：2017-04-05 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
嘻嘻哈哈
OK
lili
迷人的天抒
学术文献互助
不潮薯饼
竹青
路豐遙
GingerF
Raftaar
Criminology34
haijun
LL
skearthy
Nole
星野
清平道人
MchemG
皖公网安备34019202002308
